In recent years, it has become increasingly recognized that acromegaly is associated with an increased prevalence of colorectal cancer and pre-malignant tubular adenomas. The aetiology of these tumours is unknown but is likely to reflect increased levels of both insulin-like growth factor I (IGF-I), which is implicated in the development of sporadic colorectal cancer, and environmental factors, such as the bile acid deoxycholic acid. There is also evidence to suggest that the prevalence of breast and perhaps haematological malignancies might be increased in acromegaly, although these associations have been based on mostly small epidemiological surveys and clarification will come in the future once large-scale epidemiological studies have been completed.

1.
Wright AD, Hill DM, Lowy C, Fraser TR: Mortality in acromegaly. Q J Med 1970;39:1–16.
2.
Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R: Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 1980;12:71–79.
[PubMed]
3.
Ezzat S, Melmed S: Clinical review 18: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991;72:245–249.
[PubMed]
4.
Jenkins PJ, Besser M: Clinical perspective: Acromegaly and cancer: a problem. J Clin Endocrinol Metab 2001;86:2935–2941.
[PubMed]
5.
Turner HE, Wass JA: Modern approaches to treating acromegaly. QJM 2000;93:1–6.
[PubMed]
6.
Klein I: Acromegaly and cancer. Ann Intern Med 1984;101:706–707.
[PubMed]
7.
Ezzat S, Strom C, Melmed S: Colon polyps in acromegaly. Ann Intern Med 1991;114:754–755.
[PubMed]
8.
Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M: Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) 1997;47:17–22.
[PubMed]
9.
Renehan AG, O’Dwyer ST, Shalet SM: Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:2051–2052.
[PubMed]
10.
Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, Duysburgh I, Stevenaert A, Tabarin A, Delwaide J: The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab 1995;80:3223–3226.
[PubMed]
11.
Terzolo M, Tappero G, Borretta G, Asnaghi G, Pia A, Reimondo G, Boccuzzi A, Cesario F, Rovero E, Paccotti P, et al: High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age. Arch Intern Med 1994;154:1272–1276.
[PubMed]
12.
Ladas SD, Thalassinos NC, Ioannides G, Raptis SA: Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours? Clin Endocrinol (Oxf) 1994;41:597–601.
[PubMed]
13.
Vasen HF, van Erpecum KJ, Roelfsema F, Raue F, Koppeschaar H, Griffioen G, van Berge Henegouwen GP: Increased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol 1994;131:235–237.
[PubMed]
14.
Colao A, Balzano A, Ferone D, Panza N, Grande G, Marzullo P, Bove A, Iodice G, Merola B, Lombardi G: Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) 1997;47:23–28.
[PubMed]
15.
Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF: Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169–174.
[PubMed]
16.
Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162–168.
[PubMed]
17.
Renehan AG, Bhaskar P, Painter JE, O’Dwyer ST, Haboubi N, Ball SG, Shalet SM: The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000;85:3417–3424.
[PubMed]
18.
Jenkins PJ, Besser GM, Fairclough PD: Colorectal neoplasia in acromegaly. Gut 1999;44:585–587.
[PubMed]
19.
Tzoiti M, Akriviadis A, Papadopoulou E, Goulis I, Papagiorgiou A, Patsiaura K, Leontsini M, Arvanitakis K, Avramides A: Colon polyps prevalence in acromegalic patients (abstract). 82nd Annual Meeting of The Endocrine Society, June 2000, Toronto, Canada, 2028.
20.
Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658–662.
[PubMed]
21.
Jenkins PJ, Fairclough PD: Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut 2002;51(suppl 5):V13–V14.
22.
Nabarro JD: Acromegaly. Clin Endocrinol (Oxf) 1987;26:481–512.
[PubMed]
23.
Bengtsson BA: Acromegaly and neoplasia. J Pediatr Endocrinol 1993;6:73–78.
[PubMed]
24.
Orme SM, McNally RJ, Cartwright RA, Belchetz PE: Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab 1998;83:2730–2734.
[PubMed]
25.
Emerman JT, Leahy M, Gout PW, Bruchovsky N: Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 1985;17:421–424.
[PubMed]
26.
Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A: Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 1993;29A:492–497.
[PubMed]
27.
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393–1396.
[PubMed]
28.
Moon HD, Simpson ME, Li CH, Evans HM: Neoplasms in rats treated with pituitary growth hormone I. Pulmonary and lymphatic tissues. Cancer Res 1950;10:297–308.
[PubMed]
29.
Ray BS, Pearson OH: Hypophysectomy in treatment of disseminated breast cancer. Surg Clin North Am 1962;12:419–433.
[PubMed]
30.
Pollak MN: Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 1998;47:209–217.
[PubMed]
31.
Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA: Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nature 1998;3:1141–1144.
32.
Tornell J, Carlsson B, Pohjanen P, Wennbo H, Rymo L, Isaksson O: High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice. J Steroid Biochem Mol Biol 1992;43:237–242.
[PubMed]
33.
Yang XF, Beamer WG, Huynh H, Pollak M: Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res 1996;56:1509–1511.
[PubMed]
34.
Colao A, Marzullo P, Ferone D, Spiezia S, Cerbone G, Marino V, Di Sarno A, Merola B, Lombardi G: Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 1998;83:775–779.
[PubMed]
35.
Le Roux CW, Monson JP, Chew SL, Grossman AB, Besser GM, Jenkins PJ: Increased serum prostate specific antigen in acromegaly – a cross sectional study. J Endocrinol 2000;164(suppl):P128.
36.
Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D: Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998;90:911–915.
[PubMed]
37.
Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO: Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115–1118.
[PubMed]
38.
Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563–566.
[PubMed]
39.
Cats A, Dullaart RP, Kleibeuker JH, Kuipers F, Sluiter WJ, Hardonk, de Vries EG: Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 1996;56:523–526.
[PubMed]
40.
Jenkins PJ, Frajese V, Jones A-M, Camacho-Hubner C, Lowe DG, Fairclough PD, Chew SL, Grossman AB, Monson JP, Besser GM: IGF-I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000;85:3218–3221.
[PubMed]
41.
Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami HO, Mantzoros C: IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 1999;83:15–17.
[PubMed]
42.
Ma J, Pollak M, Giovannucci E, Chan JM, Tao Y, Hennekens CH Stampfer MJ: Prospective study of colorectal cancer risk in men and plasma levels of insulin like growth factor (IGF)-1 and IGF-binding protein-3. J Nat Cancer Inst 1999;91:620–625.
[PubMed]
43.
Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B: Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327–335.
[PubMed]
44.
Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T, Hadden DR: Ascertainment and natural history of treated acromegaly in Northern Ireland. Ulster Med J 1990;59:55–62.
[PubMed]
45.
Barzilay J, Heatley GJ, Cushing GW: Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991;151:1629–1632.
[PubMed]
46.
Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr: Acromegaly and gastrointestinal cancer. Cancer 1991;68:1673–1677.
[PubMed]
47.
Cheung NW, Boyages SC: Increased incidence of neoplasia in females with acromegaly. Clin Endocrinol (Oxf) 1997;47:323–327.
[PubMed]
48.
Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J: Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf) 1998;49:441–445.
[PubMed]
49.
Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, Helper DJ, Wiersema MJ, Langefeld CD, Li W: Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993;88:825–831.
[PubMed]
50.
Klein I, Parveen G, Gavaler JS, Vanthiel DH: Colonic polyps in patients with acromegaly. Ann Intern Med 1982;97:27–30.
[PubMed]
51.
Pines A, Rozen P, Ron E, Gilat T: Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 1985;80:266–269.
[PubMed]
52.
Ziel FH, Peters AL: Acromegaly and gastrointestinal adenocarcinomas. Ann Intern Med 1988;109:514–515.
[PubMed]
53.
Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC: Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf) 1990;32:65–71.
[PubMed]
54.
Ituarte EM, Petrini J, Hershman JM: Acromegaly and colon cancer. Ann Intern Med 1984;101:627–628.
[PubMed]
55.
Archambeaud-Mouveroux F, Geffray I, Teissier MP, Galinat S, Sautereau D, Pillegand B: Prevalence of colorectal carcinoma and polyps in acromegaly (abstract). 80th Annual Meeting of The Endocrine Society, June 1998, New Orleans, La., 2-504.
You do not currently have access to this content.